Trials / Conditions / Recurrent Nasopharyngeal Cancer
Recurrent Nasopharyngeal Cancer
4 registered clinical trials studyying Recurrent Nasopharyngeal Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis NCT01806675 | Sanjiv Sam Gambhir | Phase 1 / Phase 2 |
| Completed | Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer NCT00305734 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas NCT00101270 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatme NCT00091182 | National Cancer Institute (NCI) | Phase 2 |